ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize ZYNLONTA (loncastuximab tesirine-lpyl) in Europe and Select International...

Fort Bend Herald and Texas Coaster | Rosenberg

Jul 8, 2022

LAUSANNE, Switzerland--(BUSINESS WIRE)--Jul 8, 2022-- |!| Rosenberg